Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1444 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Achondrogenesis, Type IA | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| ACG1A; Achondrogenesis; Houston-Harris type | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Achondrogenesis type IA (ACG1A; MIM 200600), also known as achondrogenesis, Houston-Harris type, is an autosomal recessive lethal skeletal dysplasia. Individuals with achondrogenesis type IA have short trunks and severe micromelia. Clinical findings include a short neck, a barrel shaped chest, flat nasal bridge, anteverted nares, and a protuberant abdomen. Hydrops fetalis is common. Radiographic findings included wedge shaped femurs with proximal metaphyseal spikes, broad and short tibiae, and short radii. The vertebral bodies, hands and feet are unossified. Additionally, the skull is poorly ossified, and the ribs are short, beaded and may be fractured. The clavicles are short and wide and the ischia and clavicles are hypoplastic. ACG1A should be differentiated from achondrogenesis type IB and achondrogenesis type II. ACG1A is caused by mutations in the thyroid hormone receptor interactor 11 gene (TRIP11). This gene encodes the Golgi microtubule-associated protein 210 (GMAP-210). GMAP-210 is required for the glycosylation and cellular transport of several matrix proteins in chondrocytes and is important for structural organization of the Golgi. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| TRIP11 | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 200600 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Skeletal Disorders | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.